Drug Shortage Report for LANTUS
| Report ID | 213964 |
| Drug Identification Number | 02294338 |
| Brand name | LANTUS |
| Common or Proper name | Lantus Solostar |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN GLARGINE |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 3 ml |
| ATC code | A10AE |
| ATC description | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-12-20 |
| Estimated end date | 2024-02-23 |
| Actual end date | 2024-02-12 |
| Shortage status | Resolved |
| Updated date | 2024-02-13 |
| Company comments | MANUFACTURING DELAY |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-02-13 | French | Compare |
| v4 | 2024-02-13 | English | Compare |
| v3 | 2023-12-21 | English | Compare |
| v2 | 2023-12-20 | French | Compare |
| v1 | 2023-12-20 | English | Compare |
Showing 1 to 5 of 5